Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.

Sci Rep · 2024 · PMC10792074 · PMID 38228729

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

This effect was detected on circulating PBMCs as well, but due to their reduced basal expression of PD-1, it was less pronounced and did not reach statistical significance (Supplemental Fig. 3 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.